CN114208948A - Liposome for feed additive and preparation method thereof - Google Patents
Liposome for feed additive and preparation method thereof Download PDFInfo
- Publication number
- CN114208948A CN114208948A CN202111354261.XA CN202111354261A CN114208948A CN 114208948 A CN114208948 A CN 114208948A CN 202111354261 A CN202111354261 A CN 202111354261A CN 114208948 A CN114208948 A CN 114208948A
- Authority
- CN
- China
- Prior art keywords
- volatile oil
- liposome
- rhizoma atractylodis
- mixed solution
- probiotics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002502 liposome Substances 0.000 title claims abstract description 85
- 239000003674 animal food additive Substances 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000000341 volatile oil Substances 0.000 claims abstract description 140
- 239000006041 probiotic Substances 0.000 claims abstract description 49
- 235000018291 probiotics Nutrition 0.000 claims abstract description 49
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 36
- 239000000203 mixture Substances 0.000 claims abstract description 32
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 31
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 30
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 30
- 239000000463 material Substances 0.000 claims abstract description 30
- 235000013719 Houttuynia cordata Nutrition 0.000 claims abstract description 25
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 18
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 18
- 239000000787 lecithin Substances 0.000 claims abstract description 18
- 229940067606 lecithin Drugs 0.000 claims abstract description 18
- 235000010445 lecithin Nutrition 0.000 claims abstract description 18
- 238000004821 distillation Methods 0.000 claims abstract description 4
- 239000011259 mixed solution Substances 0.000 claims description 34
- 239000000843 powder Substances 0.000 claims description 15
- 238000005303 weighing Methods 0.000 claims description 15
- 239000012528 membrane Substances 0.000 claims description 14
- 238000004108 freeze drying Methods 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 150000002632 lipids Chemical class 0.000 claims description 12
- 230000002829 reductive effect Effects 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 10
- 230000000529 probiotic effect Effects 0.000 claims description 10
- 239000000725 suspension Substances 0.000 claims description 10
- 238000009210 therapy by ultrasound Methods 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 9
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 239000003223 protective agent Substances 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 238000002390 rotary evaporation Methods 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 235000013717 Houttuynia Nutrition 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 5
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 5
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 5
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 5
- 229930195725 Mannitol Natural products 0.000 claims description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 5
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 5
- UXTMROKLAAOEQO-UHFFFAOYSA-N chloroform;ethanol Chemical compound CCO.ClC(Cl)Cl UXTMROKLAAOEQO-UHFFFAOYSA-N 0.000 claims description 5
- 230000018044 dehydration Effects 0.000 claims description 5
- 238000006297 dehydration reaction Methods 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- 238000007710 freezing Methods 0.000 claims description 5
- 230000008014 freezing Effects 0.000 claims description 5
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- 239000000594 mannitol Substances 0.000 claims description 5
- 235000010355 mannitol Nutrition 0.000 claims description 5
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 238000001291 vacuum drying Methods 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 2
- 241000186000 Bifidobacterium Species 0.000 claims description 2
- 239000007853 buffer solution Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 230000000857 drug effect Effects 0.000 abstract description 8
- 244000144972 livestock Species 0.000 abstract description 5
- 244000144977 poultry Species 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 description 18
- 241001465754 Metazoa Species 0.000 description 16
- 230000000694 effects Effects 0.000 description 16
- 230000000968 intestinal effect Effects 0.000 description 13
- 230000009286 beneficial effect Effects 0.000 description 10
- 238000003860 storage Methods 0.000 description 9
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 239000008363 phosphate buffer Substances 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 6
- 241000700605 Viruses Species 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 4
- 229940117916 cinnamic aldehyde Drugs 0.000 description 4
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 4
- 210000002249 digestive system Anatomy 0.000 description 4
- 210000004994 reproductive system Anatomy 0.000 description 4
- 241000132011 Atractylodes lancea Species 0.000 description 3
- 241000186016 Bifidobacterium bifidum Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012982 microporous membrane Substances 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 235000013594 poultry meat Nutrition 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000002979 Influenza in Birds Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000758742 Saururaceae Species 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000018678 bone mineralization Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940017545 cinnamon bark Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/168—Steroids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Physiology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a liposome for a feed additive, which belongs to the technical field of livestock and poultry feed and comprises a liposome formed by lecithin and cholesterol, and a volatile oil composition and probiotics encapsulated in the liposome; wherein the volatile oil composition comprises cinnamon volatile oil, houttuynia cordata volatile oil and rhizoma atractylodis volatile oil. The invention also discloses a preparation method of the liposome, which comprises the steps of extracting cinnamon, houttuynia cordata and rhizoma atractylodis through ultrasonic-assisted distillation to obtain cinnamon volatile oil, houttuynia cordata volatile oil and rhizoma atractylodis volatile oil; and then taking lecithin and cholesterol as wall materials, and encapsulating the volatile oil composition and the probiotics to obtain the liposome. The liposome improves the stability and bioavailability of the volatile oil and the probiotics, is convenient to store and transport, and can be used as a feed additive to play the drug effects of the volatile oil and the probiotics.
Description
Technical Field
The invention relates to the technical field of livestock and poultry feed, in particular to a liposome for a feed additive and a preparation method thereof.
Background
The feed additive is a small amount or trace substance added in the production, processing and using processes of feed, and the feed additive is small in dosage but remarkable in effect. The feed additive is a raw material inevitably used in modern feed industry, and has obvious effects on strengthening the nutritive value of basic feed, improving the production performance of animals, ensuring the health of the animals, saving the feed cost, improving the quality of animal products and the like.
With the occurrence of avian influenza and the like, huge losses are brought to animal breeding owners. In order to reduce risks, the breeding owners often use antibiotics in large dose in an illegal way; in order to improve the yield, the hormone is used in large dose. The long-term or large-scale use of antibiotics causes a large amount of antibiotic residues in edible products such as livestock and poultry meat, milk and the like, poisoning or allergy of edible people occurs occasionally, and the residual hormone can cause side effects such as osteoporosis, low immune function, premature maturity of children and the like of the eaters.
The natural product contains various nutrient components and bioactive substances, has double functions of nutrition and medicines (antimicrobial, antiparasitic, anti-inflammatory and analgesic, etc.), can improve the production performance and prevent diseases, and has the characteristics of low residue, no pollution, difficult generation of drug resistance, etc. However, the natural plant extracts are generally liquid substances which are difficult to dissolve in water, if the natural plant extracts are directly added into the feed as feed additives without treatment, the natural plant extracts are not beneficial to storage and transportation of the feed, the bioavailability of the feed can be greatly reduced, the exertion of the drug effect is limited, meanwhile, the stability of the extracts is poor, and under the action of oxygen, illumination and heat, active ingredients are easy to decompose or deteriorate, so that the quality and the drug effect of the product are seriously influenced.
Disclosure of Invention
Based on the above, the invention provides the liposome for the feed additive and the preparation method thereof, the cinnamon medicinal material, the houttuynia cordata medicinal material and the rhizoma atractylodis medicinal material are extracted to obtain the volatile oil composition, and then the volatile oil composition and the probiotics are encapsulated in the liposome, so that the stability and the bioavailability of the volatile oil and the probiotics are improved, the storage and the transportation are convenient, and meanwhile, the liposome is used as the feed additive to exert the drug effects of the volatile oil and the probiotics.
The technical scheme adopted by the invention is as follows:
a liposome for feed additive and its preparation method comprise liposome formed by lecithin and cholesterol, and volatile oil composition and probiotic bacteria encapsulated in the liposome;
wherein the volatile oil composition comprises cinnamon volatile oil, houttuynia cordata volatile oil and rhizoma atractylodis volatile oil.
In the liposome for feed additive disclosed herein, the probiotic is a mixture of yeast, bacillus, bifidobacterium, lactobacillus rhamnosus and lactobacillus acidophilus.
In the liposome for feed additive disclosed in the present application, the ratio of lecithin: the mass ratio of the cholesterol is 3-5: 1.
In the liposome for feed additive disclosed in the present application, the liposome: volatile oil composition: the mass ratio of the probiotics is 10-20: 4: 1.
In the liposome for feed additive disclosed herein, the cinnamon essential oil: houttuynia volatile oil: the mass ratio of the rhizoma atractylodis volatile oil is 2-3: 1-2: 1.
The preparation method of the liposome for the feed additive comprises the following steps:
s1, extracting volatile oil
Drying and pulverizing cortex Cinnamomi, herba Houttuyniae and rhizoma Atractylodis respectively, and steam distilling to obtain cortex Cinnamomi volatile oil, herba Houttuyniae volatile oil and rhizoma Atractylodis volatile oil;
s2, preparation of liposome
S21, weighing probiotics, dissolving the probiotics in a PBS buffer solution to obtain a mixed solution 1, and keeping the temperature at 40-50 ℃ for later use;
s22, weighing cinnamon volatile oil, houttuynia cordata volatile oil, rhizoma atractylodis volatile oil, lecithin, cholesterol and an emulsifier, and dissolving the materials in a proper amount of chloroform-ethanol mixed solution to obtain a mixed solution 2;
s23, putting the mixed solution 2 into a water bath for heating, carrying out reduced pressure rotary evaporation, removing the solvent in the mixed solution 2, and drying to obtain a layer of uniform lipid membrane;
s24, adding the mixed solution 1 into a lipid membrane, and carrying out ultrasonic mixing at 60-80W for 20-40 min to obtain a suspension; emulsifying the suspension under high pressure, and filtering to obtain liposome;
s25, adding a freeze-drying protective agent into the liposome, freezing at-70 to-100 ℃, and then carrying out freeze-drying to obtain the liposome freeze-dried powder.
In the preparation method disclosed in the present application, the step S1 specifically includes: crushing the dried cinnamon medicinal material, the dried houttuynia cordata medicinal material and the dried rhizoma atractylodis medicinal material by using a crusher to obtain medicinal material powder; weighing medicinal powder, adding 5-10 times of distilled water, and carrying out ultrasonic treatment at 35-40 ℃ under 300-400W for 20-30 min; distilling and extracting the solution after ultrasonic treatment at 100-120 ℃ for 3-5 h, collecting oily substances in the distillation condensate, adding a proper amount of anhydrous sodium sulfate for dehydration, and filtering with a microporous filter membrane to obtain cinnamon volatile oil, houttuynia cordata volatile oil and rhizoma atractylodis volatile oil.
In the preparation method disclosed in the present application, the step S23 specifically includes: and (3) putting the mixed solution 2 into a water bath, carrying out reduced pressure rotary evaporation at 40-50 ℃ for 20-40 min, removing the solvent in the mixed solution 2, and drying by using a vacuum drying oven to obtain a layer of uniform lipid membrane.
In the preparation method disclosed in the present application, the emulsifier in step S22 is sodium cholate.
In the preparation method disclosed in the present application, the lyoprotectant in step S25 is one or more of trehalose, mannitol, sucrose and lactose.
The cinnamon volatile oil is a volatile component extracted from dried cinnamon bark, has a strong aromatic smell, and mainly comprises aromatic aldehydes, aromatic esters, fatty acid and mushroom compounds, wherein the content of the cinnamic aldehyde is the highest. The cinnamaldehyde has antibacterial, antioxidant, and antiviral effects. The cinnamaldehyde has obvious inhibition and killing effects on various bacteria and fungi, can directly kill viruses, and can also inhibit the replication of the viruses. The cinnamaldehyde has the functions of promoting the growth of animals, improving the utilization rate of the feed and regulating and controlling intestinal flora, and can increase the fragrance of the feed and attract the animals to eat.
The houttuynia cordata is a plant of the Saururaceae, belongs to perennial herbaceous plants, and is a medicine and a food. The houttuynia volatile oil is a main functional substance, has the effects of resisting bacteria, disinfecting, clearing heat, relieving pain, enhancing immunity of organisms and promoting urination, can be used as a feed for livestock, plays an important role in preventing and treating diseases of the livestock, and has a good application effect.
The rhizoma atractylodis is a plant of the genus atractylodis of the family Compositae, and research shows that the rhizoma atractylodis volatile oil has the functions of broad-spectrum antibiosis, antivirus, anti-inflammation, gastrointestinal movement function adjustment, bone calcification promotion and the like. The addition of the rhizoma atractylodis volatile oil in the feed has good effect on preventing infectious bronchitis, laryngitis and the like of poultry.
The probiotics are bacteria beneficial to animals, play a beneficial role by improving the ecological balance of host intestinal flora after being put into an organism, and have the effects of preventing or improving diarrhea, preventing infection of a reproductive system, enhancing the immunity of the organism, promoting the health of an intestinal digestive system, helping to absorb nutrient components and the like. The probiotic bacteria have reduced activity during storage and intestinal digestion, and are entrapped in the liposome to help protect against the invasion of gastric acid, bile and digestive enzymes.
The invention has the beneficial effects that:
extracting cortex Cinnamomi, herba Houttuyniae and rhizoma Atractylodis by ultrasonic-assisted distillation to obtain cortex Cinnamomi volatile oil, herba Houttuyniae volatile oil and rhizoma Atractylodis volatile oil. And lecithin and cholesterol are taken as wall materials, the volatile oil and the probiotics are encapsulated to form liposome, so that the stability and bioavailability of the volatile oil and the probiotics are improved, the storage and transportation are convenient, and the drug effect of the volatile oil and the probiotics is exerted as a feed additive. The prepared liposome is used as a feed additive and added into chicken feed, so that the diarrhea rate of the chicken can be obviously reduced.
Drawings
FIG. 1 is a graph showing the change in the total number of bacteria during the storage of liposomes in the present invention.
Detailed Description
In the following, only certain exemplary embodiments are briefly described. As those skilled in the art will recognize, the described embodiments may be modified in various different ways, all without departing from the spirit or scope of the present invention.
The drugs and reagents mentioned in the examples are all common commercial products unless otherwise specified.
The following provides a detailed description of embodiments of the invention.
Example 1
A liposome for feed additive comprises liposome formed from lecithin and cholesterol, and volatile oil composition and probiotic bacteria encapsulated in the liposome;
wherein the volatile oil composition comprises cinnamon volatile oil, houttuynia cordata volatile oil and atractylodes lancea volatile oil. The cinnamon volatile oil, the houttuynia cordata volatile oil and the rhizoma atractylodis volatile oil have the effects of resisting bacteria and viruses and the like, can promote the growth of animals, improve the utilization rate of feed and regulate and control the functions of intestinal flora.
The probiotic bacteria is mixture of yeast, Bacillus bifidus, Lactobacillus rhamnosus and Lactobacillus acidophilus. The probiotics are bacteria beneficial to animals, play a beneficial role by improving the ecological balance of host intestinal flora after being put into an organism, and have the effects of preventing or improving diarrhea, preventing infection of a reproductive system, enhancing the immunity of the organism, promoting the health of an intestinal digestive system, helping to absorb nutrient components and the like.
The volatile oil composition and the probiotics are encapsulated in the liposome, so that the stability and bioavailability of the volatile oil and the probiotics are improved, the storage and the transportation are convenient, and the drug effect of the volatile oil and the probiotics is exerted as a feed additive.
In a specific embodiment, the ratio of lecithin: the mass ratio of cholesterol was 3: 1.
In a specific embodiment, the liposome: volatile oil composition: the mass ratio of the probiotics is 10:4: 1.
In a specific embodiment, the ratio of cinnamon volatile oil: houttuynia volatile oil: the mass ratio of the rhizoma atractylodis volatile oil is 2:1: 1.
The preparation method of the liposome for the feed additive comprises the following steps:
s1, extracting volatile oil
Respectively crushing the dried cinnamon medicinal material, the dried houttuynia cordata medicinal material and the dried rhizoma atractylodis medicinal material by using a crusher to obtain medicinal material powder; weighing the medicinal powder, adding 5 times of distilled water, and performing ultrasonic treatment at 35 deg.C under 300W for 20 min; distilling the solution after ultrasonic treatment at 100 deg.C for 3 hr, collecting oily substance in the distillate, adding appropriate amount of anhydrous sodium sulfate for dehydration, and filtering with microporous membrane to obtain cortex Cinnamomi volatile oil, herba Houttuyniae volatile oil and rhizoma Atractylodis volatile oil. The extraction efficiency of the volatile oil can be improved by extracting the volatile oil with the assistance of ultrasonic waves.
S2, preparation of liposome
S21, weighing probiotics, dissolving the probiotics in a PBS (phosphate buffer) solution to obtain a mixed solution, and keeping the temperature at 40 ℃ for later use.
S22, weighing cinnamon volatile oil, houttuynia cordata volatile oil, rhizoma atractylodis volatile oil, lecithin, cholesterol and sodium cholate, and dissolving the materials in a proper amount of chloroform-ethanol mixed solution to obtain a mixed solution 2.
S23, putting the mixed solution 2 into a water bath, carrying out reduced pressure rotary evaporation at 40 ℃ for 20min, removing the solvent in the mixed solution 2, and drying by using a vacuum drying oven to obtain a layer of uniform lipid membrane.
S24, adding the mixed solution 1 into a lipid membrane, and carrying out ultrasonic mixing at 60W for 20min to obtain a suspension; emulsifying the suspension under high pressure, and filtering to obtain liposome.
S25, adding a freeze-drying protective agent into the liposome, freezing at-70 ℃, and then carrying out freeze-drying to obtain the liposome freeze-dried powder. The freeze-drying protective agent is one or more of trehalose, mannitol, sucrose and lactose.
The encapsulation efficiency of the liposomes of this example was 44.3% by HPLC method.
Example 2
A liposome for feed additive comprises liposome formed from lecithin and cholesterol, and volatile oil composition and probiotic bacteria encapsulated in the liposome;
wherein the volatile oil composition comprises cinnamon volatile oil, houttuynia cordata volatile oil and atractylodes lancea volatile oil. The cinnamon volatile oil, the houttuynia cordata volatile oil and the rhizoma atractylodis volatile oil have the effects of resisting bacteria and viruses and the like, can promote the growth of animals, improve the utilization rate of feed and regulate and control the functions of intestinal flora.
The probiotic bacteria is mixture of yeast, Bacillus bifidus, Lactobacillus rhamnosus and Lactobacillus acidophilus. The probiotics are bacteria beneficial to animals, play a beneficial role by improving the ecological balance of host intestinal flora after being put into an organism, and have the effects of preventing or improving diarrhea, preventing infection of a reproductive system, enhancing the immunity of the organism, promoting the health of an intestinal digestive system, helping to absorb nutrient components and the like.
The volatile oil composition and the probiotics are encapsulated in the liposome, so that the stability and bioavailability of the volatile oil and the probiotics are improved, the storage and the transportation are convenient, and the drug effect of the volatile oil and the probiotics is exerted as a feed additive.
In a specific embodiment, the ratio of lecithin: the mass ratio of cholesterol was 4: 1.
In a specific embodiment, the liposome: volatile oil composition: the mass ratio of the probiotics is 15:4: 1.
In a specific embodiment, the ratio of cinnamon volatile oil: houttuynia volatile oil: the mass ratio of the rhizoma atractylodis volatile oil is 2.5:1.5: 1.
The preparation method of the liposome for the feed additive comprises the following steps:
s1, extracting volatile oil
Respectively crushing the dried cinnamon medicinal material, the dried houttuynia cordata medicinal material and the dried rhizoma atractylodis medicinal material by using a crusher to obtain medicinal material powder; weighing the medicinal powder, adding 7 times of distilled water, and performing ultrasonic treatment at 37 deg.C under 350W for 25 min; distilling the solution after ultrasonic treatment at 110 deg.C for 4 hr, collecting oily substance in the distillate, adding appropriate amount of anhydrous sodium sulfate for dehydration, and filtering with microporous membrane to obtain cortex Cinnamomi volatile oil, herba Houttuyniae volatile oil and rhizoma Atractylodis volatile oil. The extraction efficiency of the volatile oil can be improved by extracting the volatile oil with the assistance of ultrasonic waves.
S2, preparation of liposome
S21, weighing probiotics, dissolving the probiotics in a PBS (phosphate buffer) solution to obtain a mixed solution, and keeping the temperature at 45 ℃ for later use.
S22, weighing cinnamon volatile oil, houttuynia cordata volatile oil, rhizoma atractylodis volatile oil, lecithin, cholesterol and sodium cholate, and dissolving the materials in a proper amount of chloroform-ethanol mixed solution to obtain a mixed solution 2.
S23, putting the mixed solution 2 into a water bath, carrying out reduced pressure rotary evaporation at 45 ℃ for 30min, removing the solvent in the mixed solution 2, and drying by using a vacuum drying oven to obtain a layer of uniform lipid membrane.
S24, adding the mixed solution 1 into a lipid membrane, and carrying out ultrasonic mixing at 70W for 30min to obtain a suspension; emulsifying the suspension under high pressure, and filtering to obtain liposome.
S25, adding a freeze-drying protective agent into the liposome, freezing at-85 ℃, and freeze-drying to obtain the liposome freeze-dried powder. The freeze-drying protective agent is one or more of trehalose, mannitol, sucrose and lactose.
The encapsulation efficiency of the liposome of this example was 41.7% by HPLC.
Example 3
A liposome for feed additive comprises liposome formed from lecithin and cholesterol, and volatile oil composition and probiotic bacteria encapsulated in the liposome;
wherein the volatile oil composition comprises cinnamon volatile oil, houttuynia cordata volatile oil and atractylodes lancea volatile oil. The cinnamon volatile oil, the houttuynia cordata volatile oil and the rhizoma atractylodis volatile oil have the effects of resisting bacteria and viruses and the like, can promote the growth of animals, improve the utilization rate of feed and regulate and control the functions of intestinal flora.
The probiotic bacteria is mixture of yeast, Bacillus bifidus, Lactobacillus rhamnosus and Lactobacillus acidophilus. The probiotics are bacteria beneficial to animals, play a beneficial role by improving the ecological balance of host intestinal flora after being put into an organism, and have the effects of preventing or improving diarrhea, preventing infection of a reproductive system, enhancing the immunity of the organism, promoting the health of an intestinal digestive system, helping to absorb nutrient components and the like.
The volatile oil composition and the probiotics are encapsulated in the liposome, so that the stability and bioavailability of the volatile oil and the probiotics are improved, the storage and the transportation are convenient, and the drug effect of the volatile oil and the probiotics is exerted as a feed additive.
In a specific embodiment, the ratio of lecithin: the mass ratio of cholesterol is 5:1.
In a specific embodiment, the liposome: volatile oil composition: the mass ratio of the probiotics is 20:4: 1.
In a specific embodiment, the ratio of cinnamon volatile oil: houttuynia volatile oil: the mass ratio of the rhizoma atractylodis volatile oil is 3:2: 1.
The preparation method of the liposome for the feed additive comprises the following steps:
s1, extracting volatile oil
Respectively crushing the dried cinnamon medicinal material, the dried houttuynia cordata medicinal material and the dried rhizoma atractylodis medicinal material by using a crusher to obtain medicinal material powder; weighing the medicinal powder, adding 10 times of distilled water, and performing ultrasonic treatment at 40 deg.C under 400W for 30 min; distilling the solution after ultrasonic treatment at 120 deg.C for 5 hr, collecting oily substance in the distillate, adding appropriate amount of anhydrous sodium sulfate for dehydration, and filtering with microporous membrane to obtain cortex Cinnamomi volatile oil, herba Houttuyniae volatile oil and rhizoma Atractylodis volatile oil. The extraction efficiency of the volatile oil can be improved by extracting the volatile oil with the assistance of ultrasonic waves.
S2, preparation of liposome
S21, weighing probiotics, dissolving the probiotics in a PBS (phosphate buffer) solution to obtain a mixed solution 1, and keeping the temperature at 50 ℃ for later use.
S22, weighing cinnamon volatile oil, houttuynia cordata volatile oil, rhizoma atractylodis volatile oil, lecithin, cholesterol and sodium cholate, and dissolving the materials in a proper amount of chloroform-ethanol mixed solution to obtain a mixed solution 2.
S23, putting the mixed solution 2 into a water bath, carrying out reduced pressure rotary evaporation at 50 ℃ for 40min, removing the solvent in the mixed solution 2, and drying by using a vacuum drying oven to obtain a layer of uniform lipid membrane.
S24, adding the mixed solution 1 into a lipid membrane, and carrying out ultrasonic mixing at 80W for 40min to obtain a suspension; emulsifying the suspension under high pressure, and filtering to obtain liposome.
S25, adding a freeze-drying protective agent into the liposome, freezing at-100 ℃, and then carrying out freeze-drying to obtain the liposome freeze-dried powder. The freeze-drying protective agent is one or more of trehalose, mannitol, sucrose and lactose.
The encapsulation efficiency of the liposomes of this example was 46.1% by HPLC.
Example 4
The prepared liposome is used as a feed additive for a mildew experiment
After mixing 10g of the liposome prepared in the invention in example 1, example 2 and example 3 with 2kg of feed, the mixture was placed in a constant temperature and humidity chamber with a relative humidity of 75% and a temperature of 30 +/-1 ℃, the colony growth was observed periodically by using the volatile oil composition which is not encapsulated by the liposome as a control group, and the total number of mold was measured.
The results are shown in fig. 1, and examples 1, 2 and 3 have better inhibitory effects on the growth of mold and significantly reduce the total number of mold compared to the control group. The volatile oil composition has poor stability, the active ingredients are easy to decompose or deteriorate, the antibacterial effect of the volatile oil composition is weakened along with the increase of time, the volatile oil is not easy to deteriorate after being encapsulated by the liposome, the antibacterial endurance of the volatile oil is improved, the storage is convenient, and the mildew rate of the feed additive is reduced.
Example 5
The prepared liposome serving as a feed additive is uniformly mixed with animal feed and then used for feeding animals, the effect of improving diarrhea can be realized by taking the liposome into the bodies of the animals, and the addition amount of the liposome accounts for 0.1 percent of the total mass of the animal feed when the feed is used.
The liposomes prepared in example 1, example 2 and example 3 were added to the chicken feed, 10 chicks in each group were used as an unadditized control group, 3 were repeated, and the chicks were raised for 14 days to perform experiments, and the weight change and diarrhea rate of the chicks were recorded. As shown in table 1, the addition of the liposomes prepared in examples 1, 2 and 3 reduced the diarrhea rate of the chicks compared to the control group, and example 2 showed the most significant effect.
Claims (10)
1. A liposome for feed additive is characterized in that the liposome comprises liposome formed by lecithin and cholesterol, and volatile oil composition and probiotics encapsulated in the liposome;
wherein the volatile oil composition comprises cinnamon volatile oil, houttuynia cordata volatile oil and rhizoma atractylodis volatile oil.
2. The liposome for feed additive according to claim 1, wherein the probiotic is a mixture of yeast, bacillus, bifidobacterium, lactobacillus rhamnosus and lactobacillus acidophilus.
3. The liposome for feed additive according to claim 1, wherein the ratio of lecithin: the mass ratio of the cholesterol is 3-5: 1.
4. The liposome for feed additive according to claim 1, wherein the liposome: volatile oil composition: the mass ratio of the probiotics is 10-20: 4: 1.
5. The liposome for feed additive of claim 4, wherein the cinnamon essential oil: houttuynia volatile oil: the mass ratio of the rhizoma atractylodis volatile oil is 2-3: 1-2: 1.
6. A preparation method of liposome for feed additive is characterized by comprising the following steps:
s1, extracting volatile oil
Drying and pulverizing cortex Cinnamomi, herba Houttuyniae and rhizoma Atractylodis respectively, and steam distilling to obtain cortex Cinnamomi volatile oil, herba Houttuyniae volatile oil and rhizoma Atractylodis volatile oil;
s2, preparation of liposome
S21, weighing probiotics, dissolving the probiotics in a PBS buffer solution to obtain a mixed solution 1, and keeping the temperature at 40-50 ℃ for later use;
s22, weighing cinnamon volatile oil, houttuynia cordata volatile oil, rhizoma atractylodis volatile oil, lecithin, cholesterol and an emulsifier, and dissolving the materials in a proper amount of chloroform-ethanol mixed solution to obtain a mixed solution 2;
s23, putting the mixed solution 2 into a water bath for heating, carrying out reduced pressure rotary evaporation, removing the solvent in the mixed solution 2, and drying to obtain a layer of uniform lipid membrane;
s24, adding the mixed solution 1 into a lipid membrane, and carrying out ultrasonic mixing at 60-80W for 20-40 min to obtain a suspension; emulsifying the suspension under high pressure, and filtering to obtain liposome;
s25, adding a freeze-drying protective agent into the liposome, freezing at-70 to-100 ℃, and then carrying out freeze-drying to obtain the liposome freeze-dried powder.
7. The preparation method according to claim 6, wherein the step S1 is specifically: crushing the dried cinnamon medicinal material, the dried houttuynia cordata medicinal material and the dried rhizoma atractylodis medicinal material by using a crusher to obtain medicinal material powder; weighing medicinal powder, adding 5-10 times of distilled water, and carrying out ultrasonic treatment at 35-40 ℃ under 300-400W for 20-30 min; distilling and extracting the solution after ultrasonic treatment at 100-120 ℃ for 3-5 h, collecting oily substances in the distillation condensate, adding a proper amount of anhydrous sodium sulfate for dehydration, and filtering with a microporous filter membrane to obtain cinnamon volatile oil, houttuynia cordata volatile oil and rhizoma atractylodis volatile oil.
8. The preparation method according to claim 6, wherein the step S23 is specifically: and (3) putting the mixed solution 2 into a water bath, carrying out reduced pressure rotary evaporation at 40-50 ℃ for 20-40 min, removing the solvent in the mixed solution 2, and drying by using a vacuum drying oven to obtain a layer of uniform lipid membrane.
9. The method according to claim 6, wherein the emulsifier in step S22 is sodium cholate.
10. The method according to claim 6, wherein the lyoprotectant in step S25 is one or more of trehalose, mannitol, sucrose, and lactose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111354261.XA CN114208948A (en) | 2021-11-16 | 2021-11-16 | Liposome for feed additive and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111354261.XA CN114208948A (en) | 2021-11-16 | 2021-11-16 | Liposome for feed additive and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114208948A true CN114208948A (en) | 2022-03-22 |
Family
ID=80697361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111354261.XA Pending CN114208948A (en) | 2021-11-16 | 2021-11-16 | Liposome for feed additive and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114208948A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115501211A (en) * | 2022-10-17 | 2022-12-23 | 蒋云云 | Traditional Chinese medicine gout plaster and preparation method thereof |
| CN115518107A (en) * | 2022-10-09 | 2022-12-27 | 蒋云云 | External traditional Chinese medicine preparation for treating gout and preparation method thereof |
| CN117224489A (en) * | 2022-06-08 | 2023-12-15 | 威海天原生物科技有限公司 | Plant volatile oil composition and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105876167A (en) * | 2016-04-22 | 2016-08-24 | 浙江大学宁波理工学院 | Feed additive, preparation method of feed additive and application of feed additive in livestock and poultry feeds |
| CN107047975A (en) * | 2016-12-19 | 2017-08-18 | 广东工业大学 | A kind of composition and feed addictive and preparation method thereof |
| CN108403834A (en) * | 2018-05-25 | 2018-08-17 | 成都中医药大学 | A kind of Herba Houttuyniae volatile oil Liposomal formulation and its preparation method and application |
| CN110122564A (en) * | 2019-04-25 | 2019-08-16 | 华南理工大学 | A kind of probiotics liposome and preparation method thereof |
-
2021
- 2021-11-16 CN CN202111354261.XA patent/CN114208948A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105876167A (en) * | 2016-04-22 | 2016-08-24 | 浙江大学宁波理工学院 | Feed additive, preparation method of feed additive and application of feed additive in livestock and poultry feeds |
| CN107047975A (en) * | 2016-12-19 | 2017-08-18 | 广东工业大学 | A kind of composition and feed addictive and preparation method thereof |
| CN108403834A (en) * | 2018-05-25 | 2018-08-17 | 成都中医药大学 | A kind of Herba Houttuyniae volatile oil Liposomal formulation and its preparation method and application |
| CN110122564A (en) * | 2019-04-25 | 2019-08-16 | 华南理工大学 | A kind of probiotics liposome and preparation method thereof |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117224489A (en) * | 2022-06-08 | 2023-12-15 | 威海天原生物科技有限公司 | Plant volatile oil composition and preparation method thereof |
| CN115518107A (en) * | 2022-10-09 | 2022-12-27 | 蒋云云 | External traditional Chinese medicine preparation for treating gout and preparation method thereof |
| CN115518107B (en) * | 2022-10-09 | 2023-11-03 | 北京昊坤康源医疗科学技术发展有限责任公司 | External traditional Chinese medicine preparation for treating gout and preparation method thereof |
| CN115501211A (en) * | 2022-10-17 | 2022-12-23 | 蒋云云 | Traditional Chinese medicine gout plaster and preparation method thereof |
| CN115501211B (en) * | 2022-10-17 | 2023-10-27 | 北京昊坤康源医疗科学技术发展有限责任公司 | Traditional Chinese medicine gout patch and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108813098B (en) | Microbial fermentation composite antibiotic-free feed containing natural antibiotic components | |
| CN114208948A (en) | Liposome for feed additive and preparation method thereof | |
| KR100944757B1 (en) | Probiotic materials for livestock and preparing method thereof | |
| KR101748368B1 (en) | Fermentation feed for domestic animal comprising liquid fermented sulfuric | |
| CN103330057B (en) | Composite feed supplement capable of effectively improving feed utilization ratio and preparation thereof | |
| CN108865928B (en) | Bacillus subtilis and method for preparing negundo chastetree fruit microecological preparation | |
| WO2013183805A1 (en) | Additive composition for shrimp feed and a method for producing the same | |
| CN103141702B (en) | Chinese herb extract feed additive capable of effectively preventing and treating porcine epizootic diarrhea | |
| CN110787247B (en) | Traditional Chinese medicine microecological preparation for preventing and treating livestock and poultry diarrhea and preparation method thereof | |
| CN102657287A (en) | Compound feed addictive with bacteria and oxidation resisting functions | |
| CN104206787B (en) | A kind of poultry fodder additive and preparation method thereof | |
| KR101311192B1 (en) | Production method of the Lactobacilus spp. using the medium, and method of cure of herny bee's diseases | |
| CN104872391A (en) | Cinnamon oil containing fodder bactericidal additive | |
| CN102367416A (en) | Traditional Chinese medicine probiotic solid culture medium for cow feed, culture method and feed additive | |
| KR101335081B1 (en) | The method of producing antibiotic substitute functional feed additive with fermented curcumin, capsacin and apple by-product composite having anti-viral and anti-microbial activity | |
| CN112772681B (en) | Biological compound disinfectant and preparation method thereof | |
| KR102315313B1 (en) | Pet food supplement for improving immunity and removing odor, and manufacturing method thereof | |
| KR101197451B1 (en) | A method manufacturing feed and water additives by using groats or a polar solvent extract of Illicium verum, Agastache rugosa and Atractylodes japonica | |
| CN113975310B (en) | Traditional Chinese medicine micro powder composition and application thereof in chicken ecological breeding mode | |
| CN114052116B (en) | Probiotic plant extract compound biological agent and preparation method and application thereof | |
| KR102365311B1 (en) | Feed composition for aged pets comprising herbal extracts and manufacturing method thereof | |
| KR102334386B1 (en) | Manufacturing method of functional feed for odor reduction | |
| CN113287679B (en) | Feed additive for preventing and treating colibacillosis of chickens and preparation method thereof | |
| CN107125433A (en) | Additive for farm animal feed containing Chinese medicine and preparation method thereof | |
| CN110101732B (en) | Chrysanthemum stem leaf multi-component granules with function of improving intestinal tract and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220322 |
|
| RJ01 | Rejection of invention patent application after publication |